CAS 220127-57-1 appears in our catalog under these names: Imatinib Mesylate, Gleevec (Imatinib Mesylate), >95% (HPLC), Imatinib Mesilate, Imatinib Mesylate/ 99.73% (existing batch purity), Imatinib Mesylate (STI571). Offered by: Chemat Brand, TRC, Mikromol, TargetMol, GLPBio. Available pack sizes: on request, 100mg, 10mg, 50mg, 250mg, 200mg, 500mg, 10mM (in 1ml dmso).
Imatinib methanesulfonate is a methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an anticoronaviral agent, an antineoplastic agent, a tyrosine kinase inhibitor and an apoptosis inducer. It contains an imatinib.
Source: ChEBI
| Molecular formula | C30H35N7O4S |
|---|---|
| Molecular weight | 589.7 g/mol |
| IUPAC name | methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
| InChIKey | YLMAHDNUQAMNNX-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O |
Computed by PubChem (NCBI)